Elodie Duray

The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of <i>BMI‐1</i> as an essential tumour gene

Arnold Bolomsky, Joséphine Muller, Kathrin Stangelberger et al. · British Journal of Haematology · 2020 · 32 citations · Full text

A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma

Elodie Duray, Margaux Lejeune, Frédéric Baron et al. · Journal of Hematology & Oncology · 2021 · 27 citations · Full text

Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

Joséphine Muller, Arnold Bolomsky, Sophie Dubois et al. · Haematologica · 2018 · 20 citations · Full text

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts

Joséphine Muller, Elodie Duray, Margaux Lejeune et al. · Cancers · 2019 · 19 citations · Full text

Combinatorial Design of a Nanobody that Specifically Targets Structured RNAs

Frédéric Cawez, Elodie Duray, Yaozhong Hu et al. · Journal of Molecular Biology · 2018 · 14 citations · Full text

Dna Nanotechnology, Engineering, Rna Structure Prediction +9